About
Drugs
Take action
Fluvoxamine
FAQ
Donate

Contact

We appreciate your interest.
We are no longer administered but Rockefeller Philanthropy Advisors and will be updating this page soon with details for our new initiative.  To contact Steve Kirsch, please complete the following form.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Donate to the
COVID-19 Early Treatment Fund today
Donate
Find a Trial
Apply for Funding

The COVID-19 Early Treatment Fund (CETF) is administered by Rockefeller Philanthropy Advisors, a 501(c)(3) public charity (EIN: 13-3615533). All donations to CETF are tax deductible and go exclusively towards funding outpatient trials.